Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, November 18, 2021 at 2:30 p.m. ET.

A webcast of the event will be available on the Investors section of Quantum-Si’s website under Events & Presentations. A replay will be available on the Company’s website after the event.

About Quantum-Si

Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211104006292/en/

Investor Contacts
Juan Avendano
VP of Investor Relations
(413) 537-8735
[email protected]

Mike Cavanaugh
ICR Westwicke
(617) 877-9641
[email protected]

Media Contact
Cammy Duong
ICR Westwicke
(203) 682-8380
[email protected]

Source: Quantum-Si Incorporated